UnitedHealth Group (NYSE:UNH) Stock Unloaded Rep. Maria Elvira Salazar

Representative Maria Elvira Salazar (Republican-Florida) recently sold shares of UnitedHealth Group Incorporated (NYSE:UNH). In a filing disclosed on July 07th, the Representative disclosed that they had sold between $1,001 and $15,000 in UnitedHealth Group stock on June 4th. The trade occurred in the Representative’s “UBS BROKERAGE ACCOUNT” account.

Representative Maria Elvira Salazar also recently made the following trade(s):

• Purchased $15,001 – $50,000 in shares of Voyager Technologies (NYSE:VOYG) on 6/15/2026.
• Purchased $15,001 – $50,000 in shares of Brookfield Renewable Partners (NYSE:BEP) on 6/4/2026.
• Purchased $1,001 – $15,000 in shares of Brookfield Renewable Partners (NYSE:BEP) on 6/4/2026.
• Purchased $1,001 – $15,000 in shares of Brookfield Renewable Partners (NYSE:BEP) on 6/3/2026.
• Purchased $1,001 – $15,000 in shares of Brookfield Renewable Partners (NYSE:BEP) on 6/2/2026.
• Purchased $15,001 – $50,000 in shares of Salesforce (NYSE:CRM) on 6/2/2026.
• Sold $15,001 – $50,000 in shares of Biogen (NASDAQ:BIIB) on 6/2/2026.
• Purchased $1,001 – $15,000 in shares of Brookfield Renewable Partners (NYSE:BEP) on 5/29/2026.
• Purchased $15,001 – $50,000 in shares of International Business Machines (NYSE:IBM) on 5/21/2026.
• Purchased $15,001 – $50,000 in shares of Datadog (NASDAQ:DDOG) on 5/19/2026.

UnitedHealth Group Trading Down 0.6%

Shares of NYSE:UNH opened at $425.61 on Thursday. The business has a 50 day moving average of $397.02 and a two-hundred day moving average of $337.55. The company has a market capitalization of $386.52 billion, a PE ratio of 32.15, a PEG ratio of 1.72 and a beta of 0.62. UnitedHealth Group Incorporated has a 12-month low of $234.60 and a 12-month high of $430.77. The company has a current ratio of 0.80, a quick ratio of 0.80 and a debt-to-equity ratio of 0.69.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Tuesday, April 21st. The healthcare conglomerate reported $7.23 EPS for the quarter, beating analysts’ consensus estimates of $6.76 by $0.47. UnitedHealth Group had a return on equity of 14.65% and a net margin of 2.68%.The firm had revenue of $111.65 billion for the quarter, compared to analysts’ expectations of $109.84 billion. During the same period last year, the firm earned $7.20 EPS. The company’s quarterly revenue was up 2.0% on a year-over-year basis. UnitedHealth Group has set its FY 2026 guidance at 18.250- EPS. As a group, analysts forecast that UnitedHealth Group Incorporated will post 18.32 EPS for the current year.

UnitedHealth Group Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, June 23rd. Investors of record on Monday, June 15th were given a dividend of $2.32 per share. This is an increase from UnitedHealth Group’s previous quarterly dividend of $2.21. This represents a $9.28 annualized dividend and a yield of 2.2%. The ex-dividend date was Monday, June 15th. UnitedHealth Group’s dividend payout ratio (DPR) is 70.09%.

Institutional Inflows and Outflows

Hedge funds have recently added to or reduced their stakes in the company. Affinity Capital Advisors LLC acquired a new stake in shares of UnitedHealth Group in the second quarter valued at about $322,000. Worth Asset Management LLC raised its holdings in UnitedHealth Group by 22.1% during the second quarter. Worth Asset Management LLC now owns 1,525 shares of the healthcare conglomerate’s stock worth $634,000 after purchasing an additional 276 shares during the last quarter. Beaird Harris Wealth Management LLC increased its position in shares of UnitedHealth Group by 50.0% in the second quarter. Beaird Harris Wealth Management LLC now owns 204 shares of the healthcare conglomerate’s stock valued at $85,000 after buying an additional 68 shares in the last quarter. Rockland Trust Co. increased its holdings in UnitedHealth Group by 1.1% during the 2nd quarter. Rockland Trust Co. now owns 2,589 shares of the healthcare conglomerate’s stock valued at $1,076,000 after acquiring an additional 29 shares in the last quarter. Finally, Quantum Financial Advisors LLC lifted its stake in UnitedHealth Group by 6.0% in the 2nd quarter. Quantum Financial Advisors LLC now owns 1,138 shares of the healthcare conglomerate’s stock valued at $473,000 after buying an additional 64 shares in the last quarter. Hedge funds and other institutional investors own 87.86% of the company’s stock.

Key UnitedHealth Group News

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: UnitedHealth said an external audit found nearly 97% of diagnoses in its HouseCalls home-visit unit were supported by patient medical records, which could help ease concerns about Medicare billing practices and reduce regulatory overhang. Reuters article
• Positive Sentiment: UnitedHealth is investing nearly $1.5 billion in AI for 2026 to expand automation and digital tools, which investors may view as a way to support efficiency and longer-term growth beyond cost savings. Yahoo Finance article
• Positive Sentiment: The company’s push to prioritize profitability over rapid growth, along with Optum expansion and improving margins, is being framed as a potential long-term turnaround catalyst. Yahoo Finance article
• Positive Sentiment: UnitedHealth also expanded coverage of Guardant Health’s Shield blood test for colorectal cancer screening, reinforcing its role in supporting emerging preventive-care tools. Yahoo Finance article
• Neutral Sentiment: Commentary highlighting healthcare-sector strength and a 12.41% rise in a major healthcare ETF may support sentiment for UNH, but it does not specifically change the company’s fundamentals. ETF Trends article
• Neutral Sentiment: Recent articles noting that UNH rebounded sharply in the first half and may still be undervalued suggest investors remain focused on the turnaround, though the pieces are largely opinion-based. Motley Fool article
• Negative Sentiment: New criticism from a Motley Fool piece argues that UnitedHealth may not be the best healthcare investment, which could weigh on sentiment even if it is not tied to a new company event. Motley Fool article
• Negative Sentiment: UnitedHealth and other insurers are suing states over laws targeting pharmacy businesses, and that legal fight may keep regulatory risk in focus for investors. New York Times article

Analyst Ratings Changes

UNH has been the topic of several research analyst reports. HC Wainwright set a $492.00 price objective on UnitedHealth Group in a report on Wednesday, May 27th. Robert W. Baird raised their price target on shares of UnitedHealth Group from $278.00 to $287.00 and gave the stock an “underperform” rating in a research note on Wednesday, April 22nd. Bank of America raised their target price on shares of UnitedHealth Group from $450.00 to $475.00 and gave the stock a “buy” rating in a research note on Wednesday, June 24th. TD Cowen reissued a “buy” rating on shares of UnitedHealth Group in a research note on Monday, June 22nd. Finally, Truist Financial lifted their target price on shares of UnitedHealth Group from $395.00 to $440.00 and gave the company a “buy” rating in a report on Monday, June 1st. One analyst has rated the stock with a Strong Buy rating, twenty-one have issued a Buy rating, four have assigned a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $414.75.

Insider Buying and Selling at UnitedHealth Group

In related news, CEO Patrick Hugh Conway sold 800 shares of the company’s stock in a transaction that occurred on Thursday, April 23rd. The shares were sold at an average price of $355.00, for a total transaction of $284,000.00. Following the transaction, the chief executive officer owned 17,805 shares of the company’s stock, valued at approximately $6,320,775. This represents a 4.30% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website. 0.28% of the stock is currently owned by corporate insiders.

About Representative Salazar

Maria Elvira Salazar (Republican Party) is a member of the U.S. House, representing Florida’s 27th Congressional District. She assumed office on January 3, 2021. Her current term ends on January 3, 2027.

Salazar (Republican Party) ran for re-election to the U.S. House to represent Florida’s 27th Congressional District. She won in the general election on November 5, 2024.

Maria Elvira Salazar was born in Miami, Florida, and lives in Coral Gables, Florida. Salazar earned an undergraduate degree from the University of Miami in 1983 and a graduate degree from Harvard University in 1995. Her career experience includes working as a television journalist, reporter, and news anchor.

UnitedHealth Group Company Profile

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.